Lipocine logo

Lipocine

LPCN | NASDAQ
Chart Builder DCF Calculator
$1.66
-$0.05 (-2.92%)
At close: Nov 16, 2026, 4:00 PM ET
$1.66
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.92%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #606/1021 (Top 59%)

Key Statistics

Market Data

Market Cap $18.38M
1D Range
1.64 1.71
52W Range
1.44 11.26

Valuation (TTM)

PE -1.22
PB 0.87
EV/EBITDA 0.36

Valuation (NTM)

Forward PE N/A
Forward PEG 0.04
Price Target $4.00
Loading financial charts...

Profile

Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic condi...

Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Oct 22, 2013
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.08
Beat +79.49%
REV
$2.29M
Beat +1335.78%
Next Earnings
Mar 8, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Hold
Price Target
$4.00
Upside
+140.96%
Buy (0)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.